Álvaro Lorente-Macías

13PUBLICATIONS
47CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsIndustrial molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 20, 2026
Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models.

|Apr 13, 2026
Discovery of a Highly Potent and Selective mTOR Inhibitor that Strongly Suppresses Glioblastoma Multiforme Cell Growth.

Álvaro Lorente-Macías, Jonathon Mok, John C Dawson

|Jun 26, 2025
Near-Infrared Light-Accelerated Bioorthogonal Drug Uncaging and Photothermal Ablation by Anisotropic Pd@Au Plasmonic Nanorods.

M Carmen Ortega-Liebana, Jana Travnickova, Catherine Adam

|Jan 15, 2025
Dendritic Platinum Nanoparticles Shielded by Pt-S PEGylation as Intracellular Reactors for Bioorthogonal Uncaging Chemistry.

Jose I Garcia-Peiro, M Carmen Ortega-Liebana, Catherine Adam

|Nov 04, 2024
Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

Cecilia C Ayala-Aguilera, Yang Ge, Álvaro Lorente-Macías

|Apr 26, 2024
Degron tagging for rapid protein degradation in mice.

Brianda A Hernández-Morán, Gillian Taylor, Álvaro Lorente-Macías

Pageof 3

Frequent Collaborators

9 joint publications

Asier Unciti-Broceta

3 joint publications

Neil O Carragher

2 joint publications

Vanessa Smer-Barreto

2 joint publications

M Carmen Ortega-Liebana